AUTL - Autolus cell therapy accepted for FDA review in leukemia
2024-01-22 07:20:26 ET
More on Autolus Therapeutics
- Autolus Therapeutics: Pivotal Trial Using Familiar Approach, Possible Approval Coming Fast
- Autolus Therapeutics plc (AUTL) Q3 2023 Earnings Call Transcript
- Autolus Therapeutics plc 2023 Q3 - Results - Earnings Call Presentation
- Autolus Therapeutics appoints Elisabeth Leiderman to board
- Seeking Alpha’s Quant Rating on Autolus Therapeutics
For further details see:
Autolus cell therapy accepted for FDA review in leukemia